Lymphoma Industry, May 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, in Vitro Diagnostic Reagent, Drug, Clinical Trial, Flow Cytometry, Nuclear Imaging, Antibody, Nuclear Imaging Equipment, Biomarker, Cancer Diagnostic, Cloud Computing, Oncology, Pap Smear, Pharmaceutical.


 
1-10 of about 200 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Acute Lymphoblastic ...

 B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, B-Cell Non-Hodgkin Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the B-Cell Non-Hodgkin Lymphoma. The main objective of this ...

 B-Cell Lymphomas-Pipeline Insights, 2015

B-Cell Lymphomas-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, B-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the B-Cell Lymphomas. The main objective of this report to track competito ...

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2015

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anaplastic Lymphoma Kinase (ALK) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Lymphoma Kinase (ALK) Inhibitors. ...

 T-Cell Lymphomas-Pipeline Insights, 2015

T-Cell Lymphomas-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, T-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Lymphomas. The main objective of this report to track competito ...

 Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2015

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anaplastic Large Cell Lymphoma (ALCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Large Cell Lymphoma (ALCL). The main ...

 Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peripheral T-Cell Lymphomas (PTCL). The main objective ...

 Indolent Lymphoma-Pipeline Insights, 2015

Indolent Lymphoma-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Indolent Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Indolent Lymphoma. The main objective of this report to track competito ...

 Lymphoblastic Lymphoma-Pipeline Insights, 2015

Lymphoblastic Lymphoma-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Lymphoblastic Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Lymphoblastic Lymphoma. The main objective of this report to ...

 Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Cutaneous T-Cell Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cutaneous T-Cell Lymphoma. The main objective of this report ...

About 3 900 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    33 pages
  • Cancer  

    Lymphoma  

    Chemotherapy  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.